1. Home
  2. VAL vs LIVN Comparison

VAL vs LIVN Comparison

Compare VAL & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valaris Limited

VAL

Valaris Limited

HOLD

Current Price

$50.30

Market Cap

3.9B

Sector

Energy

ML Signal

HOLD

Logo LivaNova PLC

LIVN

LivaNova PLC

HOLD

Current Price

$61.55

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VAL
LIVN
Founded
1975
1987
Country
Bermuda
United Kingdom
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.5B
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
VAL
LIVN
Price
$50.30
$61.55
Analyst Decision
Hold
Strong Buy
Analyst Count
5
8
Target Price
$54.80
$65.00
AVG Volume (30 Days)
1.1M
563.7K
Earning Date
02-18-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
5.61
N/A
Revenue
$2,416,000,000.00
$1,348,962,000.00
Revenue This Year
N/A
$12.25
Revenue Next Year
N/A
$6.75
P/E Ratio
$9.03
N/A
Revenue Growth
6.81
8.63
52 Week Low
$27.15
$32.48
52 Week High
$61.70
$65.57

Technical Indicators

Market Signals
Indicator
VAL
LIVN
Relative Strength Index (RSI) 38.97 50.58
Support Level $49.00 $61.79
Resistance Level $51.34 $63.58
Average True Range (ATR) 1.81 1.26
MACD -0.28 -0.47
Stochastic Oscillator 20.56 4.05

Price Performance

Historical Comparison
VAL
LIVN

About VAL Valaris Limited

Valaris Ltd is an offshore contract drilling company. The company provides offshore contract drilling services to the international oil and gas industry with operations in almost every offshore market across six continents. Its business consists of four operating segments: Floaters, which includes drillships and semisubmersible rigs; Jackups; ARO; and Other, which consists of management services on rigs owned by third parties. It generates the majority of its revenue from the Floaters segment.

About LIVN LivaNova PLC

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: